486 related articles for article (PubMed ID: 34944728)
21. Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver.
López-Bermudo L; Luque-Sierra A; Maya-Miles D; Gallego-Durán R; Ampuero J; Romero-Gómez M; Berná G; Martín F
Front Endocrinol (Lausanne); 2022; 13():892672. PubMed ID: 35651973
[TBL] [Abstract][Full Text] [Related]
22. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance.
Watt MJ; Miotto PM; De Nardo W; Montgomery MK
Endocr Rev; 2019 Oct; 40(5):1367-1393. PubMed ID: 31098621
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease.
Su X; Kong Y; Peng D
Clin Chim Acta; 2019 Nov; 498():30-37. PubMed ID: 31419414
[TBL] [Abstract][Full Text] [Related]
24. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases.
Vural H; Armutcu F; Akyol O; Weiskirchen R
Clin Chim Acta; 2021 Dec; 523():374-379. PubMed ID: 34678296
[TBL] [Abstract][Full Text] [Related]
25. Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues.
Mu W; Cheng XF; Liu Y; Lv QZ; Liu GL; Zhang JG; Li XY
Front Pharmacol; 2018; 9():1566. PubMed ID: 30692925
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
[TBL] [Abstract][Full Text] [Related]
27. The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease.
Qin L; Wu J; Sun X; Huang X; Huang W; Weng C; Cai J
Front Cardiovasc Med; 2023; 10():1119005. PubMed ID: 37180779
[TBL] [Abstract][Full Text] [Related]
28. Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.
Zhao J; Lei H; Wang T; Xiong X
Front Endocrinol (Lausanne); 2023; 14():1161402. PubMed ID: 36967758
[TBL] [Abstract][Full Text] [Related]
29. Critical Overview of Hepatic Factors That Link Non-Alcoholic Fatty Liver Disease and Acute Kidney Injury: Physiology and Therapeutic Implications.
Chen L; Lv X; Kan M; Wang R; Wang H; Zang H
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293317
[TBL] [Abstract][Full Text] [Related]
30. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
Targher G; Marchesini G; Byrne CD
Diabetes Metab; 2016 Jun; 42(3):142-56. PubMed ID: 27142870
[TBL] [Abstract][Full Text] [Related]
31. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease.
Li X; Wang H
Cell Biosci; 2020 Dec; 10(1):140. PubMed ID: 33372630
[TBL] [Abstract][Full Text] [Related]
32. The role of hepatokines in metabolism.
Stefan N; Häring HU
Nat Rev Endocrinol; 2013 Mar; 9(3):144-52. PubMed ID: 23337953
[TBL] [Abstract][Full Text] [Related]
33. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Zhang X; Ji X; Wang Q; Li JZ
Protein Cell; 2018 Feb; 9(2):164-177. PubMed ID: 28643267
[TBL] [Abstract][Full Text] [Related]
34. Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure.
Katsumura S; Siddiqui N; Goldsmith MR; Cheah JH; Fujikawa T; Minegishi G; Yamagata A; Yabuki Y; Kobayashi K; Shirouzu M; Inagaki T; Huang TH; Musi N; Topisirovic I; Larsson O; Morita M
Cell Metab; 2022 Apr; 34(4):564-580.e8. PubMed ID: 35385705
[TBL] [Abstract][Full Text] [Related]
35. Hepatokines as a Link between Obesity and Cardiovascular Diseases.
Yoo HJ; Choi KM
Diabetes Metab J; 2015 Feb; 39(1):10-5. PubMed ID: 25729707
[TBL] [Abstract][Full Text] [Related]
36. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice.
Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A
Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137
[TBL] [Abstract][Full Text] [Related]
37. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease-The Transition from an Adipocentric to Liver-Centric Approach.
Vesković M; Šutulović N; Hrnčić D; Stanojlović O; Macut D; Mladenović D
Curr Issues Mol Biol; 2023 Nov; 45(11):9084-9102. PubMed ID: 37998747
[TBL] [Abstract][Full Text] [Related]
38. Liver-based inter-organ communication: A disease perspective.
Luo XY; Ying SQ; Cao Y; Jin Y; Jin F; Zheng CX; Sui BD
Life Sci; 2024 Jun; 351():122824. PubMed ID: 38862061
[TBL] [Abstract][Full Text] [Related]
39. Cytokines and Abnormal Glucose and Lipid Metabolism.
Shi J; Fan J; Su Q; Yang Z
Front Endocrinol (Lausanne); 2019; 10():703. PubMed ID: 31736870
[TBL] [Abstract][Full Text] [Related]
40. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
